T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Navitas Semiconductor
NVTS
$3.61B
| $113K | ﹤0.01% |
54,932
+2,919
| +6% | +$8.36K |
|
|
PBPB
2777
DELISTED
Potbelly
PBPB
| $113K | ﹤0.01% |
11,826
+1,479
| +14% | +$16.3K |
|
2778
Mercer International
MERC
$33.9M
| $112K | ﹤0.01% |
18,123
| – | – |
|
2779
Stem
STEM
$54.5M
| $111K | ﹤0.01% |
15,720
+818
| +5% | +$9.47K |
|
|
VTYX
2780
DELISTED
Ventyx Biosciences
VTYX
| $111K | ﹤0.01% |
95,686
+54,400
| +132% | +$93.4K |
|
2781
Zentalis Pharmaceuticals
ZNTL
$303M
| $111K | ﹤0.01% |
69,685
-910,170
| -93% | -$1.96M |
|
2782
ASP Isotopes
ASPI
$549M
| $109K | ﹤0.01% |
23,121
+1,475
| +7% | +$7.36K |
|
|
EU
2783
enCore Energy
EU
$227M
| $109K | ﹤0.01% |
79,328
+7,325
| +10% | +$18.8K |
|
|
TSVT
2784
DELISTED
2seventy bio
TSVT
| $109K | ﹤0.01% |
22,033
+3,808
| +21% | +$12.1K |
|
2785
Verastem
VSTM
$614M
| $109K | ﹤0.01% |
18,052
+2,662
| +17% | +$16.3K |
|
|
ATXS
2786
DELISTED
Astria Therapeutics
ATXS
| $108K | ﹤0.01% |
20,190
+2,428
| +14% | +$17K |
|
2787
Bit Digital
BTBT
$516M
| $108K | ﹤0.01% |
53,065
+8,219
| +18% | +$23.7K |
|
2788
Viemed Healthcare
VMD
$356M
| $108K | ﹤0.01% |
14,760
+1,755
| +13% | +$13.8K |
|
|
BRY
2789
DELISTED
Berry Corp
BRY
| $105K | ﹤0.01% |
32,676
+4,493
| +16% | +$18.4K |
|
2790
Erasca
ERAS
$6.33B
| $105K | ﹤0.01% |
76,273
+6,236
| +9% | +$10.7K |
|
2791
Butterfly Network
BFLY
$2.47B
| $104K | ﹤0.01% |
45,300
| – | – |
|
2792
Century Casinos
CNTY
$35.2M
| $104K | ﹤0.01% |
61,400
| – | – |
|
2793
Vivid Seats
SEAT
$82.8M
| $104K | ﹤0.01% |
1,740
+277
| +19% | +$22.3K |
|
2794
UNIFI
UFI
$124M
| $104K | ﹤0.01% |
21,432
| – | – |
|
2795
Fossil Group
FOSL
$330M
| $103K | ﹤0.01% |
88,900
| – | – |
|
2796
Leslie's
LESL
$7.16M
| $103K | ﹤0.01% |
6,996
+1,356
| +24% | +$41.6K |
|
2797
Taysha Gene Therapies
TSHA
$1.95B
| $103K | ﹤0.01% |
74,025
+8,694
| +13% | +$14.5K |
|
|
URG
2798
Ur-Energy
URG
$533M
| $103K | ﹤0.01% |
151,937
+10,603
| +8% | +$10.4K |
|
2799
Safe Bulkers
SB
$780M
| $102K | ﹤0.01% |
27,570
+3,277
| +13% | +$11.9K |
|
|
DM
2800
DELISTED
Desktop Metal, Inc.
DM
| $102K | ﹤0.01% |
20,750
| – | – |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.